spacer
home > ict > summer 2007 > ready to recruit
PUBLICATIONS
International Clinical Trials

Ready to Recruit

Patient recruitment planning strategies can be something of a minefield. BBK Worldwide’s Elizabeth Gargill takes a country-by-country study planning approach for multinational trials

After a sponsor company employs both feasibility assessments and business rationale to the country selection process for a multinational trial, study leaders must begin to formulate a patient recruitment strategy to enrol the study. Although some recruitment tactics will be universal to all countries, this process will not be successful with a cookie-cutter approach. Healthcare systems in different countries vary significantly in their method of patient care and how physicians, institutions and regional medical facilities interact.

What’s more, how physicians in each country treat specific diseases and conditions also varies. A first-line treatment for type 2 diabetes in Austria, for example, may be diet and exercise, while physicians in Canada may take a more aggressive approach and start a newly diagnosed patient on metformin, for example, immediately. Patients diagnosed with irritable bowel syndrome in the Netherlands may be immediately referred to a specialist, while in Spain, they remain with their general practitioner for the course of their treatment.

All of these nuances will have a significant impact on how study leaders go about recruiting patients for a particular protocol within each country. Will you be able to seek physician referrals as a source for patients? Will the principal investigator’s (PI’s) panel provide sufficient patients to enrol the study? The only way to answer these questions is by gaining an understanding of the protocol and its particular challenges, and by conducting countryspecific research on how target patients are commonly treated and referred through the country’s healthcare system. Gaining knowledge of physician and patient motivations in relation to the condition and study participation will also provi

de valuable insight to apply toward recruitment strategy. Ultimately, all of this research will not only allow you to designate recruitment tactics customised to the specific needs of each country, but will also inform the cultural adaptation of recruitment messaging and serve as a research-based rationale for recruitment tactics when seeking study team buy-in and ethics committee approval. The result will be a specific recruitment strategy and successful enrolment.

BEGIN WITH PROTOCOL ANALYSIS

Reading and analysing the protocol is the important first step in recruitment planning. The inclusion and exclusion criteria will provide important rules to define the target patient, which will hold significance for each country and potentially create recruitment challenges or opportunities.

For example, in recent studies of a progressive immunological disease, one protocol required that patients be naïve to a specific drug that is a common first-line treatment in many countries. A second protocol for the same condition required patients who tried the first-line drug without successful results. The tactics for finding patients for each of these protocols for the same condition were quite different.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Elizabeth Gargill currently manages BBK Worldwide’s promotions group and sets the strategies for the agency’s publicity efforts. With 10 years’ experience in patient recruitment, her career has encompassed a variety of communications projects for both internal and client projects. She has a wealth of practice in account planning and creative strategy development, and is knowledgeable about study audience experiences and motivations. Elizabeth holds a Bachelor’s degree in English from Kenyon College and a Master’s degree in Communication from Boston University.
spacer
Elizabeth Gargill
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Clinical Trial Supply West Coast Conference 2019

Philadelphia, USA – April 24, 2019. This year’s Clinical Trial Supply West Coast Conference will see leading biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) showcasing its specialist clinical trials expertise in relation to scheduled drugs.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: 2nd Quarter 2014

Synergy Research Group

The Ministry of Health of Russian Federation approved 194 new clinical trials of all types including local and bioequivalence studies during the 2nd Quarter of 2014 (3% less than at the same period of the last year). The main contribution to the total number of studies was made by multinational multi-center clinical trials (MMCT) and the number of these studies stayed the same as in Q2 2013 – 81 studies. The number of bioequivalence studies (BE) decreased from 76 studies in Q2 2013 to 59 in Q2 2014, a 22% decrease from last year’s figure. The number of local clinical trials (LCT) increased from 42 in Q2 2013 to 54 clinical trials in Q2 2014.
More info >>

 
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement